Bing Bing Weitner

1.5k total citations
19 papers, 913 citations indexed

About

Bing Bing Weitner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Bing Bing Weitner has authored 19 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Physiology. Recurrent topics in Bing Bing Weitner's work include Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (3 papers) and Neurobiology of Language and Bilingualism (3 papers). Bing Bing Weitner is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (3 papers) and Neurobiology of Language and Bilingualism (3 papers). Bing Bing Weitner collaborates with scholars based in United States, Vietnam and Japan. Bing Bing Weitner's co-authors include Alfred Rademaker, Sandra Weıntraub, Nancy Johnson, Alissa Wicklund, Marsel Mesulam, Christina Wieneke, Cynthia K. Thompson, Soojin Cho, Melissa L. Johnson and Jyoti D. Patel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Critical Care Medicine.

In The Last Decade

Bing Bing Weitner

18 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Bing Weitner United States 16 265 203 200 179 171 19 913
E. Klieser Austria 24 323 1.2× 103 0.5× 415 2.1× 356 2.0× 86 0.5× 91 1.6k
Caterina Cerminara Italy 19 606 2.3× 187 0.9× 147 0.7× 98 0.5× 60 0.4× 41 1.1k
Tiziana Rosso Italy 16 54 0.2× 134 0.7× 353 1.8× 166 0.9× 211 1.2× 32 1.2k
C. Messa Italy 25 251 0.9× 260 1.3× 144 0.7× 130 0.7× 169 1.0× 60 1.9k
Stephen Howell United Kingdom 19 570 2.2× 164 0.8× 122 0.6× 199 1.1× 250 1.5× 31 1.2k
Anna Bladström Sweden 19 127 0.5× 79 0.4× 361 1.8× 155 0.9× 288 1.7× 29 1.7k
A. Keyser Netherlands 20 523 2.0× 93 0.5× 171 0.9× 315 1.8× 174 1.0× 59 1.5k
Christine Soufflet France 20 492 1.9× 171 0.8× 148 0.7× 298 1.7× 109 0.6× 48 1.5k
Yi Liao China 17 208 0.8× 520 2.6× 188 0.9× 272 1.5× 108 0.6× 42 1.5k
Norman C. Moore United States 15 297 1.1× 320 1.6× 350 1.8× 215 1.2× 39 0.2× 30 1.3k

Countries citing papers authored by Bing Bing Weitner

Since Specialization
Citations

This map shows the geographic impact of Bing Bing Weitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Bing Weitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Bing Weitner more than expected).

Fields of papers citing papers by Bing Bing Weitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Bing Weitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Bing Weitner. The network helps show where Bing Bing Weitner may publish in the future.

Co-authorship network of co-authors of Bing Bing Weitner

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Bing Weitner. A scholar is included among the top collaborators of Bing Bing Weitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Bing Weitner. Bing Bing Weitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Weiss, Curtis H., David W. Baker, Shayna Weiner, et al.. (2016). Low Tidal Volume Ventilation Use in Acute Respiratory Distress Syndrome*. Critical Care Medicine. 44(8). 1515–1522. 74 indexed citations
2.
Johnson, Melissa L., Helena A. Yu, Eric Hart, et al.. (2015). Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of Clinical Oncology. 33(15). 1666–1673. 91 indexed citations
3.
Kielb, Stephanie, Sandra Weıntraub, Emily Rogalskı, Bing Bing Weitner, & Alfred Rademaker. (2015). P1‐015: Subjective cognitive complaints are associated with longitudinal changes in episodic memory. Alzheimer s & Dementia. 11(7S_Part_7).
4.
Frankfurt, Olga, Shuo Ma, Leo I. Gordon, et al.. (2014). Phase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leukemia & lymphoma. 56(2). 315–323. 14 indexed citations
5.
Yazdan, Pedram, Chelsea Cooper, Lauren Meldi Sholl, et al.. (2014). Comparative Analysis of Atypical Spitz Tumors With Heterozygous Versus Homozygous 9p21 Deletions for Clinical Outcomes, Histomorphology, BRAF Mutation, and p16 Expression. The American Journal of Surgical Pathology. 38(5). 638–645. 63 indexed citations
6.
Gentzler, Ryan D., Andrew M. Evens, Alfred Rademaker, et al.. (2014). F‐18 FDG‐PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem‐cell transplantation for relapsed and refractory Hodgkin lymphoma. British Journal of Haematology. 165(6). 793–800. 29 indexed citations
7.
Ramchandran, Kavitha, Joseph W. Shega, Jamie Von Roenn, et al.. (2013). A predictive model to identify hospitalized cancer patients at risk for 30‐day mortality based on admission criteria via the electronic medical record. Cancer. 119(11). 2074–2080. 27 indexed citations
8.
Johnson, Melissa L., Eric Hart, Alfred Rademaker, et al.. (2013). A phase II study of HSP90 inhibitor AUY922 and erlotinib (E) for patients (pts) with EGFR-mutant lung cancer and acquired resistance (AR) to EGFR tyrosine kinase inhibitors (EGFR TKIs).. Journal of Clinical Oncology. 31(15_suppl). 8036–8036. 17 indexed citations
9.
Bigio, Eileen H., Sandra Weıntraub, Rosa Rademakers, et al.. (2012). Frontotemporal lobar degeneration with TDP‐43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology. 33(2). 122–133. 40 indexed citations
10.
Small, William, Mary F. Mulcahy, Alfred Rademaker, et al.. (2011). Phase II Trial of Full-Dose Gemcitabine and Bevacizumab in Combination With Attenuated Three-Dimensional Conformal Radiotherapy in Patients With Localized Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 80(2). 476–482. 45 indexed citations
11.
Thompson, Cynthia K., Soojin Cho, Christina Wieneke, et al.. (2011). Dissociations between fluency and agrammatism in primary progressive aphasia. Aphasiology. 26(1). 20–43. 111 indexed citations
12.
Ramchandran, Kavitha, Joseph W. Shega, Mark Schumacher, et al.. (2011). A predictive model to identify cancer patients at risk for in-hospital mortality based on admission criteria.. Journal of Clinical Oncology. 29(15_suppl). 6045–6045. 1 indexed citations
13.
Bigio, Eileen H., Manjari Mishra, Kimmo J. Hatanpaa, et al.. (2010). TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathologica. 120(1). 43–54. 66 indexed citations
14.
15.
Wicklund, Alissa, Nancy Johnson, Alfred Rademaker, Bing Bing Weitner, & Sandra Weıntraub. (2007). Profiles of Decline in Activities of Daily Living in Non-Alzheimer Dementia. Alzheimer Disease & Associated Disorders. 21(1). 8–13. 66 indexed citations
16.
Wicklund, Alissa, Alfred Rademaker, Nancy Johnson, Bing Bing Weitner, & Sandra Weıntraub. (2007). Rate of Cognitive Change Measured by Neuropsychologic Test Performance in 3 Distinct Dementia Syndromes. Alzheimer Disease & Associated Disorders. 21(4). S70–S78. 23 indexed citations
17.
Jason, Leonard A., Susan Torres‐Harding, Fred Friedberg, et al.. (2007). Non-pharmacologic Interventions for CFS: A Randomized Trial. Journal of Clinical Psychology in Medical Settings. 14(4). 275–296. 93 indexed citations
18.
Weıntraub, Sandra, Nancy Johnson, Marek-Marsel Mesulam, et al.. (2006). Vasectomy in Men With Primary Progressive Aphasia. Cognitive and Behavioral Neurology. 19(4). 190–193. 21 indexed citations
19.
Wicklund, Alissa, Nancy Johnson, Alfred Rademaker, Bing Bing Weitner, & Sandra Weıntraub. (2006). Word List Versus Story Memory in Alzheimer Disease and Frontotemporal Dementia. Alzheimer Disease & Associated Disorders. 20(2). 86–92. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Klieser Breakdown of academic impact, for papers by Caterina Cerminara Breakdown of academic impact, for papers by Tiziana Rosso Breakdown of academic impact, for papers by C. Messa Breakdown of academic impact, for papers by Stephen Howell Breakdown of academic impact, for papers by Anna Bladström Breakdown of academic impact, for papers by A. Keyser Breakdown of academic impact, for papers by Christine Soufflet Breakdown of academic impact, for papers by Yi Liao Breakdown of academic impact, for papers by Norman C. Moore
Rankless by CCL
2026